![](https://investorshub.advfn.com/uicon/138434.png?cb=1464725830)
Thursday, March 30, 2023 7:01:42 PM
The companies he gave as examples were Atea Pharmaceuticals, Appili Therapeutics, CytoDyn, and Humanigen, etc.
Thanks. Interesting how he’s blaming the fda. Plenty folks here had both sides of that coin. They said fda is corrupt while saying also the fda was working with rvv on steps toward approval
I would think if they couldn’t get it done as MF stated then why waste time and money and simply partner or license to a BP?? If they don’t then all hope is lost and the drug isn’t what it seems
Sure this is now option 4 in the PR so maybe one day folks will wake up to a pps above 1.00 with news of some arrangement
Gltu
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM